middl
east
respiratori
syndrom
coronaviru
merscov
fi
rst
emerg
patient
die
sever
pneumonia
saudi
arabia
al
though
case
confi
rmed
far
middl
east
sporad
unknown
sourc
infect
humantohuman
transmiss
report
healthcar
household
set
howev
sourc
viru
mode
diseas
transmiss
remain
unknown
despit
detect
small
fragment
sequenc
ident
merscov
taphoz
perforatu
bat
captur
saudi
arabia
report
crossreact
antibodi
merscov
dromedari
camel
oman
canari
island
hospit
outbreak
mer
eastern
provinc
saudi
arabia
previous
describ
full
genom
analysi
four
isol
alhasa
shock
littl
opportun
pretreat
set
invari
delay
optimum
platelet
inhibit
even
eff
ectiv
oral
agent
randomis
trial
cangrelor
versu
placebo
top
optimum
dual
oral
antiplatelet
therapi
includ
either
ticagrelor
prasugrel
would
help
solidifi
role
set
second
patient
highrisk
nonstemi
grace
score
preferenti
benefi
earli
intervent
cangrelor
rapid
onset
set
might
er
advantag
popul
third
centr
pretreat
routin
clinic
practic
cangrelor
probabl
becom
prefer
option
fourth
cangrelor
attract
option
patient
highrisk
anatom
clinic
featur
undergo
samesit
ad
hoc
elect
pci
stabl
coronari
arteri
diseas
littl
opportun
benefi
preload
patient
somewhat
surprisingli
neither
ticagrelor
prasugrel
formal
studi
larg
group
patient
final
cangrelor
er
valu
money
cost
diff
erenti
intraven
infus
cangrelor
load
dose
oral
antiplatelet
drug
ticagrelor
prasugrel
clopidogrel
like
substanti
moreov
degre
reduct
ischaem
event
make
cangrelor
overal
costeff
ectiv
strategi
major
determin
wide
use
despit
consider
favour
pharmacodynam
profi
le
eff
ectiv
reduc
periprocedur
event
make
cangrelor
use
welcom
agent
intervent
cardiologist
patient
mcmaster
univers
popul
health
research
institut
hamilton
canada
smehta
mcmasterca
outbreak
combin
fi
previous
identifi
ed
merscov
genom
investig
estim
time
recent
common
ancestor
tmrca
august
highest
posterior
densiti
hpd
novemb
april
show
four
virus
form
monophylet
clade
studi
provid
better
understand
transmiss
merscov
within
famili
cluster
healthcar
set
nevertheless
four
case
select
close
link
epidemiolog
within
outbreak
involv
four
healthcar
facil
lancet
matthew
cotten
colleagu
describ
geograph
distribut
phylogenet
relat
merscov
infect
across
time
saudi
arabia
studi
repres
largest
number
merscov
genom
describ
far
complet
eight
partial
genom
genom
coverag
clinic
mer
sampl
taken
alhasa
outbreak
four
site
saudi
arabia
riyadh
buraidah
bisha
hafralbatin
sequenc
deriv
directli
clinic
specimen
patient
thu
avoid
mutat
would
introduc
tissu
cultur
passag
author
report
three
distinct
merscov
genotyp
wherea
phylogeograph
analys
suggest
merscov
zoonot
reservoir
geograph
dispers
furthermor
genet
divers
alhasa
cluster
suggest
hospit
outbreak
might
caus
one
viru
introduct
data
obtain
clinic
mer
sampl
alhasa
cluster
commun
outbreak
record
evolut
merscov
viru
epidem
within
saudi
arabia
sequenc
variat
also
reveal
remark
multipletre
cluster
studi
provid
interest
data
support
circul
merscov
sinc
middl
estim
tmrca
juli
hpd
juli
june
although
human
exposur
result
infect
remain
unknown
studi
ad
novel
fi
nding
three
distinct
merscov
genotyp
riyadh
least
two
distinct
lineag
probabl
circul
riyadh
octob
diseas
transmiss
pattern
epidem
suggest
humantohuman
transmiss
sporad
zoonot
event
current
genom
sequenc
set
adequ
discrimin
defi
ni
tive
singl
multipl
zoonot
introduct
descript
pair
relat
genom
riyadh
bisha
descript
case
east
west
saudi
arabia
major
lineag
tree
suggest
mani
zoonot
event
overal
interest
studi
extend
earlier
fi
nding
although
report
provid
neither
direct
evid
anim
transmiss
precis
mechan
transmiss
inform
use
trace
sourc
transmiss
merscov
exampl
histor
role
scientifi
c
valu
molecular
method
trace
emerg
sever
acut
respiratori
infect
major
outbreak
sarscov
research
mani
countri
appli
molecular
genom
analysi
track
viral
evolut
spread
diseas
pcr
provid
scientifi
c
basi
direct
examin
clinic
sampl
evid
infect
similar
merscov
sequenc
variat
report
sarscov
obtain
diff
erent
patient
epidem
cotten
colleagu
eff
ectiv
shown
sequenc
variat
merscov
genom
appli
power
molecular
method
trace
rout
transmiss
use
conjunct
standard
epidemiolog
furthermor
use
publicli
releas
full
genom
sequenc
sarscov
variou
molecular
detect
method
base
rtpcr
develop
diagnost
assay
initi
focus
rna
extract
nasopharyng
aspir
urin
stool
assay
base
analysi
rna
extract
plasma
serum
later
develop
blood
rna
assay
one
target
nucleocapsid
region
polymeras
region
viru
genom
allow
standardis
quantit
express
viral
load
becam
use
earli
sar
diagnosi
detect
rate
fi
rst
week
ill
serolog
diagnosi
sar
sensit
earli
stage
quantit
system
avail
might
use
earli
diagnosi
merscov
provid
viral
load
inform
might
facilit
prognost
assess
infect
individu
increas
number
sporad
case
mer
middl
east
research
need
mode
transmiss
exposur
respons
sporad
introduct
merscov
human
popul
develop
rapid
reliabl
although
benefi
ts
continu
antismok
media
campaign
clear
littl
known
eff
ect
shortterm
programm
attempt
quit
smoke
gener
popul
lancet
timothi
mcafe
colleagu
report
nation
antismok
campaign
fund
us
center
diseas
control
prevent
call
tip
former
smoker
tip
deliv
via
televis
print
digit
media
outlet
month
develop
advertis
tip
campaign
rigor
consid
divers
set
smoker
opinion
would
help
quit
hardhit
emot
graphic
reallif
stori
produc
emphasis
eff
ect
smokingrel
diseas
qualiti
life
rather
focus
risk
death
eff
ectiv
publichealth
educ
programm
assess
baselin
followup
survey
nation
repres
sampl
adult
smoker
nonsmok
preva
lenc
smoker
report
quit
attempt
rose
period
campaign
adjust
odd
ratio
ci
mcafe
colleagu
estim
nationwid
million
addit
smoker
made
quit
attempt
tip
campaign
ci
remain
abstin
followup
furthermor
million
addit
nonsmok
recommend
cessat
servic
telephon
helplin
quit
assist
websit
million
discuss
hazard
smoke
famili
friend
studi
fi
nding
could
deem
populationspecifi
c
nonetheless
encourag
lowincom
middleincom
countri
face
major
tobacco
epidemicssuch
china
india
bangladesh
egypt
malaysia
indonesia
russiato
develop
appropri
costeff
ectiv
strategi
tobacco
control
tobacco
depend
defi
ned
chronic
diseas
process
quit
smoke
dynam
therefor
prolong
campaign
might
greater
eff
ect
global
mani
longterm
antismok
pro
gramm
deliv
howev
tip
fi
rst
feder
fund
highexposur
nation
anti
smoke
media
campaign
usa
reach
almost
us
popul
mcafe
colleagu
use
conserv
approach
estim
possibl
longterm
eff
ect
tip
campaign
fi
nding
suggest
smoker
like
becom
sustain
quitter
tip
campaign
possibl
ad
eff
ect
shortterm
massmedia
campaign
smoke
diagnost
assay
also
urgent
need
health
author
take
appropri
public
health
measur
interrupt
diseas
transmiss
contain
viru
depart
medicin
therapeut
stanley
ho
centr
emerg
infecti
diseas
chines
univers
hong
kong
hong
kong
special
administr
region
china
dschui
cuhkeduhk
